Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace

Curr Rheumatol Rep. 2017 Jul;19(7):39. doi: 10.1007/s11926-017-0667-3.

Abstract

Purpose of review: Rheumatoid vasculitis (RV) is an unusual complication of long-standing rheumatoid arthritis, which is characterized by the development of necrotizing or leukocytoclastic vasculitis involving small or medium-sized vessels. In this review, we aim to provide an update on the epidemiology, pathogenesis, clinical presentation, and management of this challenging extra-articular manifestation.

Recent findings: RV is heterogenous in its clinical presentation depending on the organ and size of blood vessels involved. The most common organs involved are the skin and peripheral nerve. Based on recent population studies, the incidence has significantly decreased with early recognition and the advent of immunosuppressive drugs and biologics; however, the mortality rates remain high. RV remains a serious extra-articular manifestation of RA that needs to be promptly recognized and treated. No consensus is available on treatment, given the ongoing debate of whether the biologics can trigger or treat RV.

Keywords: Clinical features; Extra-articular manifestations; Investigations; Pathogenesis; Rheumatoid vasculitis; Treatment.

Publication types

  • Review

MeSH terms

  • Antirheumatic Agents / therapeutic use
  • Biological Products / therapeutic use
  • Diagnosis, Differential
  • Humans
  • Prognosis
  • Rheumatoid Vasculitis / diagnosis*
  • Rheumatoid Vasculitis / drug therapy*
  • Rheumatoid Vasculitis / epidemiology
  • Rheumatoid Vasculitis / etiology

Substances

  • Antirheumatic Agents
  • Biological Products